メニュー
Request a Quote
お問い合わせ
JP

Neurological Rare Diseases

Expand your understanding of neurological rare diseases

When you hear neurological disorders, Alzheimer's and Parkinson's or other talked-about disorders such as epilepsy or stroke come to mind. However, according to the National Institute of Neurological Disorders and Stroke (NINDS), more than a third of the approximately 7,000 known rare diseases are thought to involve the nervous system. In fact, most rare diseases can be pinned to a specific genetic alteration – in some cases a single well-known genetic mutation – and are therefore at the forefront of cutting-edge genetic research. The bulk of this research is occurring in academia, geared toward fully understanding the basic mechanisms of a disease. In biotech and pharma, the research is focused on the development of novel technologies and drug discovery that may one day translate into a therapy or cure.

Revvity supports the efforts of leading scientists by offering reliable reagents and instrumentation for core gene engineering technologies such as CRISPR/Cas9 and siRNAs, library prep kits and automation solutions for next-generation sequencing, assessment of rAAV capsid generation and lentiviral transfection efficiency for research or drug development, and protein detection solutions, among others.


For research use only. Not for use in diagnostic procedures.

Neurological Rare Diseases

Explore our solutions

Genomic analysis solutions

Genomic Analysis

Eliminate your workflow challenges with our genomic analysis solutions. Our workflows increase your throughput and simplify your analysis.

Learn more

Featured resources

Webinar

Extracellular vesicles in liquid biopsies for neurological disorders

Learn more
Webinar

Dive into the world of genetic testing: a webinar review

Learn more

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ